NeuroScientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision is to transform how the pharmaceutical industry approaches the understanding and treatment of neurodegenerative disease such as Alzheimer’s Disease. We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.